Grape King BioTPE:1707 -0.11%78 FCF Margin % is 34.62% as of Dec. 2025, which is 99% above its 10-year median of 17.39. GuruFocus rates TPE:1707 with a GF Score™ of 78/100 and a GF Value™ of NT$144.03 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 962 Drug Manufacturers companies, Grape King Bio ranks better than 84.62% on this metric.
The historical rank and industry rank for Grape King Bio's FCF Margin % or its related term are showing as below:
TPE:1707'
s FCF Margin % Range Over the Past 10 Years
Min: 11 Med: 17.39 Max: 23.94
Current: 16.74
During the past 13 years, the highest FCF Margin % of Grape King Bio was 23.94%. The lowest was 11.00%. And the median was 17.39%.
TPE:1707's FCF Margin % is ranked better than 84.62% of 962
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs TPE:1707: 16.74
Grape King Bio FCF Margin % Related Terms
Grape King Bio FCF Margin % Historical Data
* Premium members only.
The historical data trend for Grape King Bio's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Grape King Bio's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grape King Bio FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grape King Bio's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Grape King Bio's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grape King Bio (TPE:1707) has a FCF Margin % of 34.62% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Grape King Bio and its competitors. This is 99% above median its historical median of 17.39. Over the past decade, Grape King Bio's FCF Margin % has ranged from 11.00 to 23.94. According to the industry distribution chart, Grape King Bio ranks #148 out of 962 companies in the Drug Manufacturers industry, placing it in the top 15.4%.
Is Grape King Bio's FCF Margin % too high?
Grape King Bio's current FCF Margin % of 34.62% is 99% above median its 10-year median of 17.39. Over the past 10 years, this metric has ranged from a low of 11.00 to a high of 23.94. The Drug Manufacturers industry median FCF Margin % is 2.51. Grape King Bio's value of 34.62% is 1279.3% above this industry median. Based on the distribution chart, Grape King Bio ranks #148 out of 962 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Grape King Bio has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Grape King Bio's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Grape King Bio ranks #148 out of 962 companies for FCF Margin %. This places Grape King Bio in the top 15% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. Grape King Bio's value of 34.62% is 1279.3% above this benchmark. Historically, Grape King Bio's own FCF Margin % has ranged from 11.00 to 23.94 over the past decade. While the company's 10-year median is 17.39 vs. the industry median of 2.51, Grape King Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grape King Bio's current FCF Margin % of 34.62% is 1279.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Grape King Bio and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grape King Bio's current FCF Margin % is 34.62%, which is 99% above median its own 10-year median of 17.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grape King Bio stock overvalued right now?
Based on GuruFocus' analysis, Grape King Bio (TPE:1707) is currently considered Possible Value Trap. The stock's GF Value™ is NT$144.03, compared to a current price of NT$91.00 — trading 36.8% below its estimated fair value. The current FCF Margin % is 34.62%, which is 99% above median its 10-year median of 17.39 and 1279.3% above the Drug Manufacturers industry median of 2.51. Grape King Bio's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Grape King Bio (TPE:1707), the current FCF Margin % is 34.62% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grape King Bio (TPE:1707) Overvalued in 2026?
Based on GuruFocus' analysis, Grape King Bio stock appears to be undervalued.
The current stock price of NT$91.00 is trading 36.8% below its estimated GF Value™ of NT$144.03.
GuruFocus considers Grape King Bio to be Possible Value Trap.
Key valuation signals for TPE:1707:
FCF Margin %: 34.62% (99% above median its 10-year median of 17.39)
GF Value™: NT$144.03 vs. price of NT$91.00 (36.8% below fair value)
Industry Position: 1279.3% above the Drug Manufacturers median (#148 of 962)
No single metric tells the full story. See the TPE:1707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food. The company has three segments: MLM (Multi-Level Marketing), which is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, the Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
78GF Score
Get the complete analysis for TPE:1707
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1707 has been successfully added to your 
